NNT721 - NANOPARTICULATE DRUG DELIVERY SYSTEMS
Course Name | Code | Semester | Theory (hours/week) |
Application (hours/week) |
Credit | ECTS |
---|---|---|---|---|---|---|
NANOPARTICULATE DRUG DELIVERY SYSTEMS | NNT721 | Any Semester/Year | 3 | 0 | 3 | 9 |
Prequisites | None | |||||
Course language | Turkish | |||||
Course type | Elective | |||||
Mode of Delivery | Face-to-Face | |||||
Learning and teaching strategies | Lecture Discussion | |||||
Instructor (s) | Assist. Prof. Dr. Cem Varan | |||||
Course objective | Providing information about preparation, characterization, stability, drug release mechanisms, administration routes, utilization, and quality control of nanoparticulate drug carrier systems | |||||
Learning outcomes |
| |||||
Course Content | Preparation, characterization, stability, drug release mechanisms, administration routes, utilization, and quality control of nanoparticulate drug carrier systems | |||||
References | Lecture notes, internet. Nanoparticles for Pharmaceutical Applications, Ed: A.J. Domb, Y.Tabato, M.N.V. Ravi Kumar and S Farber. Nanoparticle Technology for Drug Delivery, Ed: Ram B. Gupta, Uday B. Kompella |
Course outline weekly
Weeks | Topics |
---|---|
Week 1 | Introduction of nanoparticular systems and the technological parameters effecting the formulation |
Week 2 | Biopharmaceutical parameters effecting the formulation of nanoparticular systems |
Week 3 | Bioavailability of nanoparticular systems |
Week 4 | Niosome definition, preparation, advantages and disadvantages, release mechanism of active ingredient |
Week 5 | Microemulsions, nanoemulsions, solid lipid nanospheres (SNL) and nanostructures lipid carriers (NLC): Definition, preparation, advantages and disadvantages, release mechanism of active ingredient |
Week 6 | Liposome definition, preparation, advantages and disadvantages, release mechanism of active ingredient |
Week 7 | Self emulsifying drug delivery systems (SEDDS) |
Week 8 | Midterm exam |
Week 9 | Safety and toxicology of nanoparticular drug delivery systems |
Week 10 | Nanopspheres, nanocapsules: Definition, preparation, advantages and disadvantages, release mechanism of active ingredient |
Week 11 | In viro characterization, quality control and stability of nanoparticular drug delivery systems |
Week 12 | Applications and examples of nanoparticular drug delivery systems |
Week 13 | Regulations of nanoparticular drug delivery systems |
Week 14 | Final sınavı |
Assesment methods
Course activities | Number | Percentage |
---|---|---|
Attendance | 0 | 0 |
Laboratory | 0 | 0 |
Application | 0 | 0 |
Field activities | 0 | 0 |
Specific practical training | 0 | 0 |
Assignments | 0 | 0 |
Presentation | 0 | 0 |
Project | 0 | 0 |
Seminar | 0 | 0 |
Midterms | 1 | 50 |
Final exam | 1 | 50 |
Total | 100 | |
Percentage of semester activities contributing grade succes | 0 | 50 |
Percentage of final exam contributing grade succes | 0 | 50 |
Total | 100 |
WORKLOAD AND ECTS CALCULATION
Activities | Number | Duration (hour) | Total Work Load |
---|---|---|---|
Course Duration (x14) | 14 | 3 | 42 |
Laboratory | 0 | 0 | 0 |
Application | 0 | 0 | 0 |
Specific practical training | 0 | 0 | 0 |
Field activities | 0 | 0 | 0 |
Study Hours Out of Class (Preliminary work, reinforcement, ect) | 14 | 7 | 98 |
Presentation / Seminar Preparation | 1 | 10 | 10 |
Project | 0 | 0 | 0 |
Homework assignment | 2 | 10 | 20 |
Midterms (Study duration) | 1 | 50 | 50 |
Final Exam (Study duration) | 1 | 50 | 50 |
Total Workload | 33 | 130 | 270 |
Matrix Of The Course Learning Outcomes Versus Program Outcomes
D.9. Key Learning Outcomes | Contrubition level* | ||||
---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | |
1. To be able to use mathematics, science and engineering knowledge to develop new methods in nanotechnology and nanomedicine | X | ||||
2. To have comprehensive information on the current techniques and methods applied in nanotechnology and nanomedicine | X | ||||
3. To develop methods and tools for the identification and understanding of functions and interaction mechanisms at the atomic and molecular level | X | ||||
4. To understand the effects of universal and social aspects in nanotechnology and nanomedicine applications. | X | ||||
5. To be able to use new technological developments, databases and other knowledge sources efficiently by adopting the importance of life-long learning | X | ||||
6. To acquire the ability of analysis, synthesis and evaluation of new ideas and developments in nanotechnology and nanomedicine | X | ||||
7. To have awareness of entrepreneurship and innovativeness | X | ||||
8. To be able to design an experiment, analyze and interpret the experimental results as a written report. | X | ||||
9. An ability to perform disciplinary and interdisciplinary team work | X | ||||
10. An ability to present the results of the studies orally or written in national and international platforms and contribute to the scientific literature. | X | ||||
11. To have consciousness about professional ethics and social responsibility | X |
*1 Lowest, 2 Low, 3 Average, 4 High, 5 Highest